Showing results (61-70 of 104) with videos related to
Sort By:
Pageof 11
Clinical Pharmacology and Therapeutics|March 1, 1983
Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusionW E Evans, P R Hutson, C F Stewart, et al.Lancet (London, England)|February 18, 1984
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemiaW E Evans, W R Crom, C F Stewart, et al.Anesthesia and Analgesia|March 1, 1986
Pharmacokinetics of fentanyl in neonatesD E Koehntop, J H Rodman, D M Brundage, et al.Journal of Clinical Pharmacology|May 1, 1988
Pharmacokinetics and pharmacodynamics of urapidil in severe hypertensionM B Bottorff, T J Hoon, J H Rodman, et al.Drug Intelligence & Clinical Pharmacy|November 1, 1982
Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemiaW E Evans, C F Stewart, P R Hutson, et al.The Journal of Pediatrics|October 1, 1987
Pharmacokinetics and toxicity of methotrexate in children with Down syndrome and acute lymphocytic leukemiaM L Garré, M V Relling, D Kalwinsky, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1984
The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexateW R Crom, C B Pratt, A A Green, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Clinical pharmacodynamic studies of high-dose methotrexate in acute lymphocytic leukemiaW E Evans, M Abromowitch, W R Crom, et al.Cancer Chemotherapy and Pharmacology|January 1, 1981
Cisplatin disposition in children and adolescents with cancerW R Crom, W E Evans, C B Pratt, et al.The New England Journal of Medicine|February 20, 1986
Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effectW E Evans, W R Crom, M Abromowitch, et al.Pageof 11